Results 181 to 190 of about 264,257 (370)

Cross-validated Bagged Prediction of Survival [PDF]

open access: yes, 2005
In this article, we show how to apply our previously proposed Deletion/Substitution/Addition algorithm in the context of right-censoring for the prediction of survival.
Neugebauer, Romain   +2 more
core   +1 more source

Artificial intelligence-based assessment of PD-L1 expression in diffuse large B cell lymphoma [PDF]

open access: gold
Fang Yan   +15 more
openalex   +1 more source

Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma

open access: green, 2021
Stefan Alig   +22 more
openalex   +2 more sources

Long‐Term Dermoscopic Evolution of Reticular Erythematous Mucinosis: Case Report

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Reticular erythematous mucinosis is a rare dermatosis with a challenging diagnosis. To date, its dermoscopic features have not been well characterised in the literature. Only a limited number of case reports have described dermoscopic findings that may be indicative of the disorder, including the presence of dotted and linear vessels, as well ...
Grażyna Kamińska‐Winciorek   +4 more
wiley   +1 more source

Diffuse Large B-cell Lymphoma of the Testis [PDF]

open access: yesMayo Clinic Proceedings, 2016
Rosalind F, Sandell, Lori A, Erickson
openaire   +2 more sources

BRIDGING TO TRANSPLANT IN DIFFUSE LARGE B CELL LYMPHOMA

open access: yesEuropean Medical Journal Hematology, 2016
Non-Hodgkin lymphoma (NHL) is the eighth most common malignancy worldwide. Diffuse large B cell lymphoma (DLBCL) is the most frequent subtype, accounting for >30% of NHL cases.
Christian Gisselbrecht   +1 more
doaj  

Kaempferitrin's Dual Assault: Inducing Apoptosis and Ferroptosis in Diffuse Large B‐Cell Lymphoma via NF‐κB Inactivation

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) is the most common non‐Hodgkin lymphoma and is an aggressive and highly heterogeneous tumor. Kaempferitrin (KPF) is a natural flavonoid glycoside that exerts a protective role in multiple human tumors. However, the impact of KPF on DLBCL remains unclear.
Han‐Shuo Zhang   +3 more
wiley   +1 more source

Inhibition of MALT1 protease activity is selectively toxic for activated B cell–like diffuse large B cell lymphoma cells [PDF]

open access: bronze, 2009
Uta Ferch   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy